Published in Mol Endocrinol on June 01, 1999
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res (2000) 1.38
Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J Bone Miner Res (2005) 1.23
Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis. CPT Pharmacometrics Syst Pharmacol (2012) 1.06
Effects of chronic estrogen treatment on modulating age-related bone loss in female mice. J Bone Miner Res (2010) 1.04
TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction. Endocrinology (2011) 0.90
Hormonal regulation of physiological cell turnover and apoptosis. Cell Tissue Res (2000) 0.89
Oestrogen deficiency modulates particle-induced osteolysis. Arthritis Res Ther (2011) 0.88
Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone. Bone (2011) 0.87
Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors. J Cell Biochem (2008) 0.86
Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist. Clinics (Sao Paulo) (2012) 0.85
Effect of in utero exposure to diethylstilbestrol on lumbar and femoral bone, articular cartilage, and the intervertebral disc in male and female adult mice progeny with and without swimming exercise. Arthritis Res Ther (2012) 0.84
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res Ther (2003) 0.84
Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice. Am J Physiol Endocrinol Metab (2008) 0.83
Cyclin G2 suppresses estrogen-mediated osteogenesis through inhibition of Wnt/β-catenin signaling. PLoS One (2014) 0.79
The dietary ingredient, genistein, stimulates cathelicidin antimicrobial peptide expression through a novel S1P-dependent mechanism. J Nutr Biochem (2014) 0.79
Transcriptional activation of insulin-like growth factor binding protein 6 by 17beta-estradiol in SaOS-2 cells. Exp Mol Med (2009) 0.78
Interaction of interleukin-6 and estrogen receptor gene polymorphisms on bone mass accrual in Chinese adolescent girls. J Bone Miner Metab (2008) 0.77
Differentially expressed genes and signalling pathways are involved in mouse osteoblast-like MC3T3-E1 cells exposed to 17-β estradiol. Int J Oral Sci (2014) 0.77
Estrogen potentiates the combined effects of transforming growth factor-beta and tumor necrosis factor-alpha on adult human osteoblast-like cell prostaglandin E2 biosynthesis. Calcif Tissue Int (2003) 0.75
Oestradiol levels may differ between premenopausal women, ages 18-50, with type 1 diabetes and matched controls. Diabetes Metab Res Rev (2016) 0.75
Effects of estrogens and estrogenic disrupting compounds on fish mineralized tissues. Mar Drugs (2014) 0.75
Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein. J Clin Med (2017) 0.75
Involutional osteoporosis. N Engl J Med (1986) 8.20
Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
beta-Lactamase proceeds via an acyl-enzyme intermediate. Interaction of the Escherichia coli RTEM enzyme with cefoxitin. Biochemistry (1980) 3.94
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Weekend hospitalization and additional risk of death: an analysis of inpatient data. J R Soc Med (2012) 3.77
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Evidence of estrogen receptors in normal human osteoblast-like cells. Science (1988) 2.85
Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology (1999) 2.65
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Idiopathic osteoporosis--is the osteoblast to blame? J Clin Endocrinol Metab (1997) 2.25
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest (1979) 2.21
Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17
Incidence of Colles' fracture in a North American community. Am J Public Health (1982) 2.17
Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res (1996) 2.16
The effects of vault drainage on postoperative morbidity after vaginal hysterectomy for benign gynaecological disease: a randomised controlled trial. BJOG (2011) 2.03
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res (2000) 1.98
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res (1995) 1.97
Epidemiology of sarcopenia. J Am Geriatr Soc (2000) 1.97
Skeletal effects of estrogen. Endocr Rev (1994) 1.91
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med (1984) 1.90
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
Classification of vertebral fractures. J Bone Miner Res (1991) 1.89
Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab (1996) 1.79
Bone density and fracture risk in men. J Bone Miner Res (1998) 1.77
Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int (2008) 1.73
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Assessing forearm fracture risk in postmenopausal women. Osteoporos Int (2009) 1.71
Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest (1983) 1.69
Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest (1971) 1.68
Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest (1997) 1.67
Genomic imprinting in mammals: an interplay between chromatin and DNA methylation? Trends Genet (1999) 1.67
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart (2005) 1.65
Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A (1991) 1.65
Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J Nucl Med (1977) 1.63
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry (1986) 1.57
Relationship between body composition and bone mass in women. J Bone Miner Res (1996) 1.57
DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol (2001) 1.55
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int (1995) 1.51
Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med (1972) 1.50
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Psychiatric morbidity in patients referred to an insomnia clinic. Singapore Med J (2007) 1.46
Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res (1999) 1.44
Bone densitometry and clinical decision-making in osteoporosis. Ann Intern Med (1988) 1.43
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology (2000) 1.43
Effect of gender on outcomes following renal artery stent placement for renovascular hypertension. Cathet Cardiovasc Diagn (1997) 1.43
Colles' fracture and subsequent hip fracture risk. Clin Orthop Relat Res (1983) 1.43
Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med (1974) 1.42
Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry. Radiology (1980) 1.42
Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40
Three-year follow-up on effects of transdermal estrogen. Ann Intern Med (1996) 1.39
Rotational atherectomy for left anterior descending artery septal perforator stenosis. Catheter Cardiovasc Interv (1999) 1.39
Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest (1977) 1.37
Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab (1980) 1.37
Cross-sectional versus longitudinal evaluation of bone loss in men and women. Osteoporos Int (2000) 1.37
Effect of sex hormones on bone in primary osteoporosis. J Clin Invest (1969) 1.36
Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med (1998) 1.36
The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med (1997) 1.35
Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int (2008) 1.35
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun (1998) 1.33
Individual susceptibility to noise-induced hearing loss: an old topic revisited. Ear Hear (1993) 1.33
Risk factors for injury after a fall. Clin Geriatr Med (1985) 1.33
Correlates of osteoprotegerin levels in women and men. Osteoporos Int (2002) 1.31
Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci U S A (1991) 1.31